IL10 and neoplasm: Sun et al. [49] reported that circulating tumor-specific CD8+ T cells in advanced melanoma with high PD-1 expression also have high expression levels of IL-10R and that the level of IL-10R expression can be further increased by PD-1/PD-L1 blockade, making these T cells more sensitive to IL-10.